Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables
Open Access
- 31 July 2006
- journal article
- research article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 195 (1), 72-77
- https://doi.org/10.1016/j.ajog.2005.12.007
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Contraceptive vaginal rings releasing Nestorone® and ethinylestradiol: a 1-year dose-finding trialContraception, 2005
- Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptivesJournal of Thrombosis and Haemostasis, 2004
- New delivery systems in contraception: vaginal ringsAmerican Journal of Obstetrics and Gynecology, 2004
- Two-year performance of a Nestorone®-releasing contraceptive implant: a three-center study of 300 womenContraception, 2004
- Nestorone®: clinical applications for contraception and HRTSteroids, 2003
- The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter studyContraception, 2003
- The association between extrinsic activated protein C resistance and venous thromboembolism in womenContraception, 2002
- Nestorone®: a progestin with a unique pharmacological profileSteroids, 2000
- Update 1996: Blood collection and handling procedures for assessment of plasminogen activators and inhibitors (Leiden Fibrinolysis Workshop)Fibrinolysis, 1996
- Evaluation of four different contraceptive vaginal rings: Steroid serum levels, luteal activity. bleeding control and lipid profilesContraception, 1992